Eris Lifesciences Ltd vs Remedium Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 17, 2026

Key Highlights

The Latest Trading Price of ERIS Lifesciences Ltd is ₹ 1373 as of 15 May 15:30 . The P/E Ratio of ERIS Lifesciences Ltd changed from 54.8 on March 2025 to 29.2 on March 2024 . This represents a CAGR of -11.83% over 5 yearsThe P/E Ratio of Remedium Lifecare Ltd changed from 36.4 on March 2025 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years The Market Cap of ERIS Lifesciences Ltd changed from ₹ 19287 crore on March 2025 to ₹ 11442 crore on March 2024 . This represents a CAGR of -9.92% over 5 yearsThe Market Cap of Remedium Lifecare Ltd changed from ₹ 73.38 crore on March 2025 to ₹ 0 crore on March 2024 . This represents a CAGR of -100.00% over 5 years The revenue of ERIS Lifesciences Ltd for the Dec '25 is ₹ 807.59 crore as compare to the Sep '25 revenue of ₹ 795.5 crore. This represent the growth of 1.52% The revenue of Remedium Lifecare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 114.31 crore. This represent the decline of -100% The ebitda of ERIS Lifesciences Ltd for the Dec '25 is ₹ 264.51 crore as compare to the Sep '25 ebitda of ₹ 291.3 crore. This represent the decline of -9.2% The ebitda of Remedium Lifecare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 10.62 crore. This represent the decline of -100% The net profit of ERIS Lifesciences Ltd changed from ₹ 89.55 crore to ₹ 108.83 crore over 7 quarters. This represents a CAGR of 11.79% The net profit of Remedium Lifecare Ltd changed from ₹ -2.05 crore to ₹ 0 crore over 4 quarters. This represents a CAGR of -100.00% The Dividend Payout of ERIS Lifesciences Ltd changed from 21.3 % on March 2021 to 129.35 % on March 2025 . This represents a CAGR of 43.44% over 5 yearsThe Dividend Payout of Remedium Lifecare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About ERIS Lifesciences Ltd

Eris Lifesciences Limited was incorporated on January 25, 2007.
Subsequently, the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9, 2007.
Further, the Company was converted into a Public Limited cCompany and the name was changed to 'Eris Lifesciences Limited' on February 2, 2017.
The Company has a manufacturing plant in Guwahati, Assam and is presently engaged in manufacturing and marketing of pharmaceutical products.
It has presence in high growth chronic, sub chronic and acute therapeutic areas that require high intervention of specialist and super specialist doctors. The company develops, manufactures and commercializes branded pharmaceutical products in selected therapeutic areas within chronic and acute categories of the Indian Pharmaceutical Market (IPM), such as: cardiovascular; anti-diabetics; vitamins; gastroenterology; and anti-infective.

About Remedium Lifecare Ltd

Remedium Lifecare Limited (Formerly known as 'Roxy Exports Limited) was incorporated in February 19, 1988.
Consequent to change in the business activities and accordingly, in order to keep the name of the Company in consonance with the new business activities, the Company changed its name from 'Roxy Exports Limited' to 'Remedium Lifecare Limited' vide a fresh Certificate of Incorporation on November 6, 2020 issued by the Registrar of Companies. The Company being a pharmaceutical company is aligned across two business verticals viz. products and services.
Products business comprises trading and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. Apart from this, the Company is engaged in the business of trading in Advanced Pharmaceutical Intermediates, Active Pharmaceutical Ingredients (API's) and other pharma products used viz.

FAQs for the comparison of ERIS Lifesciences Ltd and Remedium Lifecare Ltd

Which company has a larger market capitalization, ERIS Lifesciences Ltd or Remedium Lifecare Ltd?

Market cap of ERIS Lifesciences Ltd is 19,038 Cr while Market cap of Remedium Lifecare Ltd is 37 Cr

What are the key factors driving the stock performance of ERIS Lifesciences Ltd and Remedium Lifecare Ltd?

The stock performance of ERIS Lifesciences Ltd and Remedium Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for ERIS Lifesciences Ltd and Remedium Lifecare Ltd?

As of May 17, 2026, the ERIS Lifesciences Ltd stock price is INR ₹1373.95. On the other hand, Remedium Lifecare Ltd stock price is INR ₹0.42.

How do dividend payouts of ERIS Lifesciences Ltd and Remedium Lifecare Ltd compare?

To compare the dividend payouts of ERIS Lifesciences Ltd and Remedium Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.